Fig 1.
Algorithm used to define the study cohort.
Table 1.
Baseline characteristics according to quartiles of eGFR variability in all patients and patients without AR.
Fig 2.
Kaplan–Meier curves for the median time of graft survival according to eGFR variability.
Upper panel: Kaplan–Meier survival curves for graft failure by quartiles of the means of serially measured eGFR values in all patients (A) and in patients without AR (B) (black: quartile 1, black dotted: quartile 2, gray: quartile 3, gray dotted: quartile 4). Lower panel: Kaplan–Meier survival curves for graft failure by quartiles of the CV of serially measured eGFR values in all patients (C) and in patients without AR (D) (black: quartile 4, black dotted: quartile 3, gray: quartile 2, gray dotted: quartile 1). Black and gray lines indicate the quartile of eGFR-means or eGFR-CV values. eGFR: estimated glomerular filtration rate; AR: acute rejection; CV: coefficient of variation of eGFR.
Table 2.
Cox regression model for graft failure by quartiles of eGFR variability.
Table 3.
Cox regression model for death by quartiles of eGFR variability.
Fig 3.
Kaplan–Meier survival curves for graft failure by using the cutoff of the eGFR-CV of serially measured eGFR values in all patients (A) and in patients without AR (B).
Black and gray lines indicate the cutoff of eGFR-CV (black: higher-CV, gray: lower-CV). eGFR: estimated glomerular filtration rate; AR: acute rejection; CV: coefficient of variation of eGFR; higher-CV: higher values than the cutoff of eGFR-CV; lower-CV: lower values than the cutoff of eGFR-CV.
Table 4.
Cox regression model for graft failure and death by using the cutoff of eGFR variability.